Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc."
Results 181 - 200
of 284
Sorted by Relevance
|
Sort by Date
28 Jul 2015, 11:52 am
Merrell Dow Pharmaceuticals Inc., 43 F.3d 1311, 1320 (9th Cir.), cert. denied 516 U.S. 869 (1995) [Daubert II]. [read post]
31 Mar 2016, 8:09 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), nor did Tyson offer a rebuttal expert witness. [read post]
24 Jun 2011, 1:24 pm
” Wal-Mart Stores, Inc. v. [read post]
8 Jul 2010, 3:30 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
26 Oct 2010, 4:30 am
Merrell Dow Pharmaceuticals, decided by the Supreme Court in 1993. [read post]
20 Jul 2008, 2:00 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993)).Now Frye is a more conservative test. [read post]
28 Jun 2012, 5:52 am
Merrell Dow Pharmaceuticals apply to expert evidence offered at class certification? [read post]
28 Jun 2012, 5:52 am
Merrell Dow Pharmaceuticals apply to expert evidence offered at class certification? [read post]
16 Feb 2013, 7:23 am
Merrell Dow Pharmaceuticals, Inc., 509, U.S. 579 (1993). [read post]
19 Aug 2013, 8:10 am
In a landmark decision, Daubert v. [read post]
11 Aug 2021, 5:00 am
Merrell Dow Pharmaceuticals Inc. [read post]
1 May 2008, 11:21 am
Beretta USA, Inc., No. 05-6942-cv (2d Cir. [read post]
16 Jun 2017, 7:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), the Supreme Court case upon which the standard for expert testimony is based, seeks to exclude the testimony of an expert witness that is not relevant or reliable. [read post]
6 Dec 2013, 9:22 am
Merrel Dow Pharmaceuticals, Inc. (1993) 509 U.S. 579. [read post]
11 May 2020, 1:09 am
That was the tradition that stood in active need of reform when Daubert was decided in 1993. [read post]
24 Aug 2010, 11:34 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), in which the Court instructed district courts to function as gatekeepers and permit only reliable and relevant expert testimony to be presented to the jury. [read post]
3 Jan 2015, 3:47 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) and granted BNSF’s motion for summary judgment. [read post]
9 Oct 2018, 5:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), there are several factors that should be considered by a court when determining the admissibility of expert testimony. [read post]
28 Apr 2008, 6:06 am
Merrell Dow Pharmaceuticals, Inc. [read post]
3 May 2022, 10:28 am
In Daubert v. [read post]
